Journal of Biochemistry and Cell Biology
Open Access

Cellular biochemistry; Molecular pathways; Signal transduction; Metabolism; Disease mechanisms; Protein homeostasis

Introduction

Cellular biochemistry is the study of the molecular processes that sustain the life and function of cells [1]. It encompasses the biochemical pathways and interactions that regulate cellular processes such as energy production, cell signaling, growth, differentiation, and maintenance of cellular integrity. These processes are critical for maintaining cellular homeostasis, allowing cells to respond to external stimuli, repair damage, and adapt to changes in the environment [2]. At the heart of cellular biochemistry are various molecular pathways that control fundamental cellular functions. Metabolism, for instance, involves the biochemical processes by which cells convert nutrients into energy, primarily through glycolysis and oxidative phosphorylation, which fuel all other cellular activities [3]. Signal transduction pathways, such as the MAPK/ERK and PI3K/Akt pathways, transmit external signals to the nucleus, driving processes like cell proliferation, survival, and differentiation. Similarly, cellular machinery responsible for protein homeostasis, including the ubiquitin-proteasome system, regulates the degradation and turnover of proteins, ensuring the proper function and balance of cellular proteins.

The proper regulation of these pathways is essential for normal cell function. Dysregulation or mutations in these pathways can lead to the development of a range of diseases. For example, mutations in key metabolic enzymes can contribute to metabolic disorders such as diabetes or obesity [4]. Aberrant activation of signaling pathways, such as that regulating cell growth, is commonly observed in cancer. Furthermore, defects in protein homeostasis are implicated in neurodegenerative diseases, such as Alzheimer's and Parkinson's. Given the central role of these molecular pathways in health and disease, understanding the mechanisms that govern them is crucial for developing targeted therapies. By identifying key points of dysfunction in cellular biochemical networks, researchers can design interventions to correct these imbalances, offering potential treatments for a variety of diseases [5]. This review explores the major molecular pathways in cellular biochemistry, highlighting their importance in maintaining cellular function and their contributions to disease when disrupted.

Results and Discussion

Key molecular pathways in cellular biochemistry

The molecular pathways governing cellular functions are highly integrated and regulate a wide array of essential processes, from energy metabolism to cell signaling, protein synthesis, and degradation [6]. This section discusses the primary pathways involved in maintaining cellular homeostasis and their roles in disease development when dysregulated.

Metabolic pathways: glycolysis and oxidative phosphorylation

Metabolism plays a central role in cellular biochemistry by providing the energy required for cell survival, proliferation, and function. The two primary processes involved in energy production are glycolysis and oxidative phosphorylation [7]. Glycolysis, the breakdown of glucose into pyruvate, is essential for energy generation, particularly in the absence of oxygen. In rapidly dividing cells, such as those in tumors, the Warburg effect (a shift toward glycolysis even in the presence of oxygen) is often observed, providing a survival advantage by supporting biosynthesis and rapid growth. Oxidative phosphorylation in the mitochondria, which produces ATP via the electron transport chain, is the primary source of energy in most cells. Dysregulation in these metabolic pathways, such as mutations in enzymes like pyruvate dehydrogenase or mitochondrial DNA, can lead to metabolic diseases, including diabetes, obesity, and mitochondrial disorders. Additionally, the altered metabolic states in cancers (e.g., enhanced glycolysis) are being actively explored as therapeutic targets.

Signal transduction pathways: MAPK/ERK and PI3K/Akt

Cellular signaling pathways are responsible for transmitting information from the extracellular environment to the nucleus, enabling cells to respond to changes such as stress, growth signals, or damage. The MAPK/ERK pathway, which is involved in cell proliferation and differentiation, is frequently mutated in various cancers, leading to uncontrolled cell division and resistance to apoptosis. Oncogenic mutations in RAS proteins, which activate the MAPK/ERK pathway, are common in cancers such as pancreatic, colorectal, and lung cancer. Similarly, the PI3K/Akt pathway is a key regulator of cell survival and metabolism [8]. PTEN, a tumor suppressor, regulates this pathway by deactivating PI3K, and its loss is frequently observed in cancers. Activation of Akt promotes cell survival by inhibiting pro-apoptotic proteins and stimulating cell growth. This pathway’s role in promoting angiogenesis (formation of new blood vessels) and resistance to chemotherapy makes it a critical target for cancer therapeutics.

Protein homeostasis and the ubiquitin-proteasome system

Protein homeostasis (proteostasis) ensures that cells maintain a balance between protein synthesis and degradation, which is crucial for cell function. The ubiquitin-proteasome system (UPS) plays a central role in protein degradation by tagging damaged or unnecessary proteins with ubiquitin, marking them for degradation by the proteasome [9]. This system regulates key cellular functions, including cell cycle progression, DNA repair, and stress responses. Dysregulation of the UPS can lead to the accumulation of misfolded or damaged proteins, contributing to a variety of diseases. For example, in neurodegenerative diseases such as Parkinson's disease and Alzheimer’s disease, the accumulation of amyloid plaques or alpha-synuclein aggregates is often due to impaired protein degradation. In cancer, aberrant regulation of the UPS can contribute to the degradation of tumor suppressors, allowing uncontrolled cell proliferation. Thus, targeting the UPS for therapeutic intervention holds promise for treating neurodegenerative diseases and cancer.

Pathway interactions and disease mechanisms

The molecular pathways discussed above do not operate in isolation but interact extensively with each other. For example, the PI3K/Akt pathway can influence metabolic pathways, and metabolic shifts can alter the activation of signaling networks. In cancer, these interactions are often amplified, leading to the development of resistance to therapies. For instance, the MAPK/ERK and PI3K/Akt pathways often cross-talk to regulate cell survival, making them targets for combination therapies.

In cancer, the aberrant activation of multiple signaling and metabolic pathways is a hallmark of tumorigenesis. Oncogenes like RAS and Myc often induce changes in metabolic pathways, creating a metabolic environment conducive to tumor growth. These changes include increased glycolysis, alterations in mitochondrial function, and enhanced protein synthesis. Similarly, the PI3K/Akt pathway often cooperates with the MAPK pathway to enhance cell survival and proliferation in tumor cells. Understanding how these pathways are interconnected is critical for developing therapeutic strategies that target multiple aspects of cancer biology. In neurodegenerative diseases, the accumulation of misfolded proteins due to defects in the UPS can impair cellular function and lead to neuronal death. Dysregulation of protein synthesis and degradation also contributes to Alzheimer’s and Parkinson’s disease, where tau protein and alpha-synuclein aggregates, respectively, accumulate in the brain. Therapeutic approaches that restore proper protein turnover, such as enhancing the proteasome function or inhibiting protein aggregation, are being actively explored for these diseases. Metabolic disorders such as diabetes and obesity are similarly linked to defects in the regulation of metabolic pathways, particularly those controlling insulin signaling, glucose uptake, and lipid metabolism. In these diseases, defects in insulin signaling pathways, particularly involving the PI3K/Akt pathway, result in insulin resistance, a key feature of type 2 diabetes.

Therapeutic implications

The insights into molecular pathways in cellular biochemistry have profound implications for the development of therapeutic interventions. In cancer, targeting specific signaling pathways like MAPK/ERK or PI3K/Akt has led to the development of targeted therapies, such as BRAF inhibitors and PI3K inhibitors, which aim to block the pathways that drive tumor growth. However, the development of drug resistance remains a significant challenge, and combination therapies targeting multiple pathways or the tumor microenvironment are being actively investigated [10]. In neurodegenerative diseases, restoring protein homeostasis through proteasome activators or inhibiting protein aggregation represents a promising therapeutic strategy. Similarly, targeting metabolic pathways, such as those controlling glycolysis or oxidative phosphorylation, offers new avenues for treating metabolic diseases like diabetes and obesity.

Conclusion

Understanding the molecular pathways involved in cellular biochemistry is essential for comprehending the fundamental processes that maintain cellular homeostasis and the role of dysregulated pathways in disease. Key pathways such as metabolism, signal transduction, and protein homeostasis are intricately linked to cellular functions, and their disruption can lead to diseases such as cancer, metabolic disorders, and neurodegenerative diseases. As our understanding of these pathways deepens, the potential for targeted therapies increases, offering new opportunities for the treatment of complex diseases. The future of cellular biochemistry lies in harnessing these insights to develop more effective, precise, and personalized treatments.

Acknowledgement

None

Conflict of Interest

None

References

1. Baek M, DiMaio F, Anishchenko I, Dauparas J, Ovchinnikov S, et al. (2021) Accurate prediction of protein structures and interactions using a three‐track neural network. Sci 373: 871-6.

Indexed at, Google Scholar, Crossref

2. White FH (1961) Regeneration of native secondary and tertiary structures by air oxidation of reduced ribonuclease. J Biol Chem 236: 1353-1360.

Indexed at, Google Scholar

3. Anfinsen CB, Haber E (1961) Studies on the reduction and re-formation of protein disulfide bonds. J Biol Chem 236: 1361-1363.

Indexed at, Google Scholar

4. Bai Y, Englander SW (1996) Future directions in folding: the multi-state nature of protein structure. Proteins 24: 145-51.

Indexed at, Google Scholar, Crossref

5. Bai Y, Milne JS, Mayne L, Englander SW (1993) Primary structure effects on peptide group hydrogen exchange. Proteins 17: 75-86.

Indexed at, Google Scholar, Crossref

6. Alonso DO, Daggett V (2000) Staphylococcal protein A: unfolding pathways, unfolded states, and differences between the B and E domains. Proc Natl Acad Sci U S A 97: 133-8.

Indexed at, Google Scholar, Crossref

7. Arai M, Kuwajima K (2000) Role of the molten globule state in protein folding. Adv Protein Chem 53: 209-82.

Indexed at, Google Scholar, Crossref

8. Arora P, Oas TG, Myers JK (2004) Fast and faster: a designed variant of the B‐domain of protein A folds in 3 microsec. Protein Sci 13: 847-53.

Indexed at, Google Scholar, Crossref

9. Bai Y, Milne JS, Mayne L, Englander SW (1994) Protein stability parameters measured by hydrogen exchange. Proteins 20: 4-14.

Indexed at, Google Scholar, Crossref

10. Bai Y, Sosnick TR, Mayne L, Englander SW (1995) Protein folding intermediates: native-state hydrogen exchange. Sci 269: 192-97.

Indexed at, Google Scholar, Crossref